| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 402,767 | 403,120 | 402,014 | 429,233 | | Cost of Revenue | 195,959 | 193,368 | 191,753 | 198,568 | | | Gross Profit | 206,808 | 209,752 | 210,261 | 230,665 | | | Operating Expenses | | Research Development | 22,700 | 23,407 | 24,428 | 23,793 | | Selling General and Administrative | 94,746 | 94,574 | 97,969 | 100,513 | | Non Recurring | 797 |
-
| 2,340,023 |
-
| | Others | 12,854 | 13,025 | 12,693 | 12,638 | | | | Total Operating Expenses | 131,097 |
-
| 2,475,113 |
-
| | | | Operating Income or Loss | 75,711 | 78,746 | (2,264,852) | 93,721 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 987 | (524) | (327) | (2,635) | | Earnings Before Interest And Taxes | 76,698 | 78,222 | (2,265,179) | 91,086 | | Interest Expense | 16,445 | 17,552 | 17,095 | 18,410 | | Income Before Tax | 60,253 | 60,670 | (2,282,274) | 72,676 | | Income Tax Expense | 25,313 | 19,670 | 17,896 | 24,683 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 34,940 | 41,000 | (2,300,170) | 47,993 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 34,940 | 41,000 | (2,300,170) | 47,993 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $34,940 | $41,000 | ($2,300,170) | $47,993 |
|
0.02% Nasdaq 
Income Statement
